Stevanato Group Spa Dossier
Qualitative Analysis
Business overview
Stevanato Group S.p.A. (NYSE: STVN) is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. Founded in 1949 and headquartered in Piombino Dese, Italy, the company operates through two primary segments: Biopharmaceutical and Diagnostic Solutions (BDS), and Engineering. Stevanato is the world's leading producer of insulin cartridges and the second-largest producer of pre-fillable syringes globally. Its comprehensive portfolio spans high-value containment solutions, drug delivery systems (such as pen injectors and auto-injectors), and specialized engineering machinery for glass converting and assembly.
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Scaling up manufacturing capabilities for pre-filled syringes and ready-to-use (RTU) cartridges at key sites in Cisterna di Latina, Italy, and Fishers, Indiana, USA.
Expected impact: Enables the company to meet surging global demand for injectable biologics, biosimilars, and GLP-1 therapies.
Introduction of Deora, a multi-use, fixed-dose pen injector platform designed for incretin-based therapies (GLP-1 and obesity treatments) utilizing standard 1.5 mL and 3 mL cartridges.
Expected impact: Simplifies the injection sequence, reduces user error, and integrates seamlessly into existing pharmaceutical fill-finish lines.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Collaborating to create a pre-verified, large-volume subcutaneous drug delivery ecosystem integrating Stevanato's EZ-fill cartridges with advanced plungers and wearable devices.
Terms: Not disclosed
Medisca distributes Stevanato Group's EZ-fill ready-to-use (RTU) sterile glass vials, expanding access to premium packaging solutions for the sterile compounding industry.
Terms: Long-term strategic agreement effective as of December 2024, with online purchase availability starting in early 2026.
Formed the 'Alliance for RTU' to share technical expertise and accelerate market adoption of Ready-to-Use (RTU) vials and cartridges over conventional bulk packaging.
Terms: Cooperative open expert platform